Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 121 | 70 | 162 | 205 | 165 |
| Gross Profit | 121 | 70 | 162 | 205 | 165 |
| Operating Expenses | 726 | 784 | 962 | 987 | 849 |
| Operating Income | -605 | -714 | -800 | -782 | -684 |
| Interest Expense | 59 | 62 | 51 | 45 | 48 |
| Other Income | 0 | 0 | 16 | 0 | -1 |
| Pre-tax Income | -663 | -776 | -835 | -828 | -733 |
| Net Income Continuous | -663 | -776 | -835 | -828 | -733 |
| Net Income | $-663 | $-776 | $-835 | $-828 | $-733 |
| EBITDA(a) | $-603 | $-712 | $-798 | $-780 | $-682 |